Cite
MLA Citation
Laura Tsujikawa et al.. “Apabetalone (RVX-208) Lowers Risk of Major Adverse Cardiovascular Events (MACE) in T2D Patients with CVD By Attenuating Monocyte Adhesion to Endothelial Cells.” Atherosclerosis, vol. 32, 2018, pp. 104–. http://access.bl.uk/ark:/81055/vdc_100066061881.0x000011